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Ziziphus mauritiana (Lamk.) is a fruit tree that has folkloric implications against many ailments and diseases. In the present study,
anticancer potential of seed extract of Ziziphus mauritiana in vitro against diﬀerent cell lines (HL-60, Molt-4, HeLa, and normal
cell line HGF) by MTT assay as well as in vivo against Ehrich ascites carcinoma bearing Swiss albino mice was investigated. The
extract was found to markedly inhibit the proliferation of HL-60 cells. Annexin and PI binding of treated HL-60 cells indicated
apoptosis induction by extract in a dose-dependent manner. The cell cycle analysis revealed a prominent increase in sub Go
population at concentration of 20μg/mland above. Agarosegel electrophoresis conﬁrmed DNA fragmentation inHL-60cells after
3 h incubation with extract. The extract also exhibited potent anticancer potential in vivo. Treatment of Ehrlich ascites carcinoma
bearing Swiss albino mice with varied doses (100–800mg/kg b.wt.) of plant extract signiﬁcantly reduced tumor volume and viable
tumor cell count and improved haemoglobin content, RBC count, mean survival time, tumor inhibition, and percentage life span.
The enhanced antioxidant status in extract-treated animals was evident from decline in levels of lipid peroxidation and increased
levels of glutathione, catalase, and superoxide dismutase.
1.Introduction
The plant-derived compounds have always been an impor-
tant source of medicines for various diseases and have
received considerable attention in recent years due to their
diverse pharmacological properties including cytotoxic and
cancer chemopreventive eﬀects [1]. During the last few
years, novel chemopreventive agents of natural origin have
been targeted with fruits and vegetables being a key interest
due to high content of bioactive compounds [2]. Cancer is
the second leading cause of death all over the world [3].
According to World Health Organization, more than 10
million new cases of cancer are diagnosed every year, and the
statistical trends indicate that this number would double by
2020 [4]. Cancer is the uncontrolled growth and spread of
abnormal cells, associated with dysregulation of apoptosis, a
programmedcelldeath.Mostofthecurrentanticancerdrugs
are derived from plant sources, which act through diﬀerent
pathways converging ultimately into activation of apoptosis
in cancer cells leading to cell cytotoxicity.
Ziziphus mauritiana commonly known as Indian jujube
is a fruit tree belonging to family Rhamnaceae. Traditionally,
thefruithasbeenusedasanodyne,sedative,tonicanticancer,
potent wound healer, applied on cuts and ulcers and has also
been used against asthma [5, 6]. The extracts from fruits
[7], leaves [8, 9], and seeds [10]o fZiziphus mauritiana have
been reported to exhibit antioxidant activity, whereas bark
[11, 12] and pulp [13] are reported to possess cytotoxicity
against diﬀerent cancer cell lines. Keeping above in view,
the present study was aimed at investigating the eﬀect
of aqueous-ethanolic seed extract of Ziziphus mauritiana
against diﬀerent cancer cell lines in vitro and against Ehrlich
ascites carcinoma in vivo.
2.MaterialsandMethods
2.1. Chemicals and Reagents. 3-(4,5-dimethylthiazole-2- yl)-
2,5-diphenyltetrazolium bromide (MTT), RPMI-1640, L-
glutamine, penicillin, streptomycin, HEPES, 2-mercaptoeth-
anol, propidium iodine (PI), DNase free RNase, proteinase2 Evidence-Based Complementary and Alternative Medicine
K, 2-Deoxy-D-ribose, ascorbic acid, and 1,1-diphenyl-2-
picrylhydrazyl(DPPH)werepurchasedfromSigmachemical
Co, St. Louis, USA. Fetal Bovine serum (FBS) was purchased
from GIBCO Invitrogen Corporation, USA. Annexin V-
FITC apoptosis detection kit and Cycle test were purchased
from BD Bioscience, USA. Electrophoresis apparatus and
reagents were procured from Biorad, USA. Trichloro acetic
acid (TCA), Thiobarbituric acid (TBA), and pyragallol were
purchased from Merck, USA. All other chemicals used were
of analytical grade, available locally.
2.2. Plant Source, Extract Preparation, and Standardiza-
tion (ZMS). Fruits of Ziziphus mauritiana (Lamk.), variety
Umran were collected from Botanical Gardens of Punjabi
University, Patiala, Punjab, India and authenticated by Pro-
fessor R.C. Gupta, Botany Department, Punjabi University,
Patiala,Punjab,India.PlantsamplehasbeenkeptinVoucher
specimen DOB (305) PUP at Punjabi University, Patiala.
Aqueous-ethanolic seed extract of Ziziphus mauritiana
(ZMS) was prepared and standardized as described earlier
[14].
2.3. Anticancer Activity of ZMS In Vitro
2.3.1. Cell Lines, Growth Conditions, and Treatment. Human
promyelocytic leukemia cells (HL-60), acute lymphoblastic
leukemia cells (Molt-4), human cervical cancer cells (HeLa)
cells, and normal human gingival ﬁbroblast cells (HGF) were
obtained from National Cancer Institute (NCI), Bethesda,
USA.
The cells were grown in RPMI-1640 medium, sup-
plemented with 10% heat-inactivated fetal bovine serum
(FBS), penicillin (100units/mL), streptomycin (100μg/mL),
HEPES 15mM, L-glutamine (0.3mg/mL), pyruvic acid
(0.11mg/mL), 2-mercaptoethanol (50μM), and NaHCO3
(0.37%) and incubated at 37
◦C in an atmosphere of 95% air
and 5% CO2, with 98% humidity. ZMS was dissolved in 30%
dimethyl sulfoxide (DMSO) and delivered to cell culture in
complete medium while the controls received only DMSO
(<0.2%, v/v).
2.3.2. Cell Proliferation Assay. Cell proliferation was assessed
according to the method of Shashi et al. [15]. Brieﬂy,
200μL of medium containing 2.5 × 104 cells obtained from
diﬀerent cell lines (HL-60, Molt-4, HeLa cells, and HGF)
were seeded in each well of 96-well microtiter plates. Cells
were incubated with diﬀerent concentrations of ZMS for
48 hrs at 37
◦C, 5% CO2 with 98% humidity. The medium
was replaced with fresh medium containing 100μg/mL of
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) for 4 hrs. The supernatant was aspirated and
MTT-formazan crystals were dissolved in 100μLD M S O .
Absorbance was measured at 570nm. Cell growth was
calculated by comparing the absorbance of treated and
untreated cells. Cell line showing maximum sensitivity was
subjected to further study.
2.3.3. Flow Cytometric Analysis of Apoptosis and Necrosis.
Flow cytometric analysis of apoptosis and necrosis was done
by method of Del Bino et al. [16]. HL-60 cells treated
with ZMS were washed twice with phosphate buﬀered saline
(PBS) and then resuspended in 100μL of binding buﬀer
provided with apoptosis detection kit (BD Pharmingin).
Cells were stained with annexin-V FITC antibody and
PI as per instructions provided by the manufacturer and
scanned for ﬂuorescence intensity in FL-1 (FITC) and FL-2
(PI) channels. The fractions of cell population in diﬀerent
quadrants were analyzed using quadrant statistics. Cells in
the lower right quadrant represented apoptosis and in the
upper right represented postapoptotic necrosis.
2.3.4. DNA Content and Cell Cycle Phase Distribution. Cell
cycle phase distribution was done by the method of Del Bino
et al. [16]. Cells were treated with diﬀerent concentrations of
ZMSfor24hrsandcollectedat160 ×gfor5minutesin5mL
polystyrenetubes.CellswerewashedoncewithPBSandﬁxed
in 70% ethanol overnight at 4◦C. Cells were again washed
with PBS, resuspended in 250μL PBS, incubated with RNase
at37
◦C,andstainedwithpropidiumiodineusingprocedures
and reagents as described in the instruction manual. The
preparations were analyzed for DNA content using BD-LSR
ﬂow cytometer. Data were collected in list mode on 10,000
events for FL2-A versus FL2-W.
2.3.5.DNAFragmentation. DNAfragmentationwasassessed
by electrophoresis of extracted genomic DNA from HL-
6 0c e l l sa sd e s c r i b e db yM u l l e re ta l .[ 17] with slight
modiﬁcations. Brieﬂy, 2 × 106 cells were incubated with
diﬀerent concentrations of ZMS for 24 hours and washed
with PBS containing 10mM EDTA. The pellet was lysed in
250μLo fl y s i sb u ﬀer (100mM NaCl, 5mM EDTA, 10mM
Tris-HCl, pH 8.0, 5% Triton X-100, 0.25% SDS), containing
400μg/mL DNase-free RNase and incubated at 37
◦Cf o r9 0
minutes followed by 1 hour incubation with proteinase-
K (200μg/mL) at 50
◦C .D N Aw a se x t r a c t e dw i t h2 0 0 μL
of phenol:chloroform:isoamyl alcohol (25:24:1) for 1
minute and centrifuged at 13000 × gf o r3m i n u t e s .T h e
aqueous phase was further extracted with chloroform and
centrifuged. DNA was precipitated from aqueous phase with
3volumesofchilledalcoholcontaining0.3Msodiumacetate
at 4◦C overnight. The precipitate was centrifuged at 13000 ×
g for 10 minutes. DNA pellet was washed with 80% alcohol,
dried, dissolved in 50μLT Eb u ﬀer and electrophoresed in
1.8%agarosegelat50V,stainedwithethidiumbromide,and
visualized in Bio-rad Gel Documentation System.
For the time-dependent study, 2 × 106 cells were
incubated with speciﬁed concentrations of ZMS for 24 hours
and studied at diﬀerent time intervals.
2.4. Anticancer Activity of ZMS In Vivo
2.4.1.Animals. MaleSwissalbinomice(18–22g)maintained
on standard laboratory diet (Kisan Feeds Ltd., Mumbai,
India), having free access to tap water, were employed in the
present study. The animals were housed in the departmental
animalhouseandexposedto12hourscycleoflightanddark.
Experimental protocol was approved by Institutional Animal
Ethics Committee and care of the animals was carried out asEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Proliferation inhibition in diﬀerent human cell lines upon ZMS treatment. ZMS at indicated concentrations were evaluated for
its in vitro cytotoxicity against diﬀerent cancer cell lines (HL-60, HeLa, and Molt-4) and normal cell line (HGF) employing MTT reduction
assay. The results are expressed as percent of cell growth inhibition determined relative to untreated control cells. Data are mean value ±
S.E.M. (n = 8) and representative of one of the three similar experiments.
per the guidelines of Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEAs),
Ministry of Environment and Forests, Government of India
(Reg. no. 107/1999/CPCSEA).
2.4.2. Acute Toxicity. The acute toxicity of Ziziphus mauri-
tiana seed extract was assessed as described earlier [18].
2.4.3. Experimental Design. Ehrlich Ascites Carcinoma
(EAC) cells maintained in the peritoneal cavity of Swiss
albino mice (male) were collected from an animal having
8–10 days old ascitic tumor by aspirating the ascitic ﬂuid
in sterile isotonic saline. The viable EAC cells were counted
(trypan blue indicator) under microscope. Male Swiss albino
mice weighing 18–22g were injected with 1 × 107 EAC
cells intraperitoneally on day 0. A day of incubation was
allowed for multiplication of the cells. On day 1, the
animals were randomized and divided into seven groups
(n = 10), namely, Group I, vehicle (Distilled water, i.p);
Group II, Control 5-ﬂuorouracil (20mg/kgb.wt.); Group
III, extract (100mg/kgb.wt.); Group IV, extract (200mg/kg
b.wt.); Group V, extract (400mg/kg b.wt.); Group VI,
extract (800mg/kg b.wt.); Group VII, Control (1 × 107 EAC
cells). Test groups were treated with plant extract prepared
in distilled water intraperitoneally at the interval of 24
hours from day 1 to day 9. Positive control group was
treated with 5-ﬂuorouracil (commercial anticancer drug)
from day 1 to day 9, parallel control group was treated
with distilled water only. The animals were sacriﬁced on day
13 by cervical dislocation and tumor volume, tumor cell
count,hematologicalparametersandantioxidantstatuswere
assessed. The second set of animals was continued with the
similar design so as to observe their life span.
2.4.4. Tumor Growth Response. The antitumor eﬀect of ZMS
wasassessedbychangeinbodyweight,ascitestumorvolume,
viable tumor cell count, percentage tumor inhibition, mean
survival time and percentage increased life span [19, 20].
The tumor growth inhibition was calculated as follows:
% tumor inhibition
= 1 −Av. No. o fc e l l si nt e s tg r o u p
/Av. No. of cells in control group ×100.
(1)
The eﬀect of ZMS on tumor growth was monitored by
recording the mortality for the period of 40 days and
percentage increase in life span was calculated as follows:
%I L S
=

Mean survival time of treated group
/Mean survival time of control group ×100

− 1

,
Mean Survival
=

Day of 1st death+Day of last death

/2.
(2)
Body weight of the animals was recorded both in treated
and control groups at the beginning of the experiment and
subsequently on every 5th day.
2.4.5.HematologicalStudies. Bloodwascollectedfromretro-
orbital plexus of animals and used for the estimation of
hemoglobin (Hb) content, red blood cell count (RBC),
and white blood cell count (WBC) [21] and animals were
sacriﬁced by cervical dislocation.
2.4.6. Biochemical Assays. The liver of animals was excised,
rinsed in ice-cold normal saline followed by 0.15M Tris-
HCl (pH 7.4), blotted dry, and weighed. A 10% (w/v)
homogenates was prepared in 0.15M Tris-HCl buﬀer and4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Flow cytometric analysis of ZMS-induced apoptosis and necrosis in HL-60 cells using annexinV-FITC and PI double staining. HL-
60 cells (1 × 106/mL) were incubated with indicated concentrations of ZMS for 12 hours and stained with Annexin V-FITC/PI. Quadrant
analysis of ﬂuorescence intensity of ungated cells in FL-1 versus FL-2 channels was from 10000 events. Cells in the lower right quadrant
represented apoptosis while in the upper right quadrant indicated postapoptotic necrosis and representative of one of the three similar
experiments.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Cell cycle analysis in HL-60 cells after ZMS treatment. HL-60 cells (1 × 106/mL) were treated with diﬀerent concentration of
ZMS for 24 hours. Cells were stained with PI to determine DNA ﬂuorescence by ﬂow cytometer. Sub-GO population indicative of DNA
damage was analyzed from the hypodiploid sub-Go fraction (<2n DNA) of DNA cell cycle analysis. The cells for hypodiploid (sub GO/G1,
<2n DNA) population were analyzed from FL2-A versus cell counts shown in % and representative of one of the three similar experiments.6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Dose-dependent and time-dependent induction of DNA fragmentation in HL-60 cells after ZMS treatment. (a) 2 × 106 HL-60
cells treated with diﬀerent concentrations of ZMS extract for 24 hours. DNA was electrophoresed on 1.8% agarose gel and stained with
ethidium bromide. M-Marker; C-Untreated HL-60 cells; 10-10μg/mL of ZMS treated HL-60 cells; 20-20μg/mL of ZMS treated HL-60 cells;
40-40μg/mL of ZMS treated HL-60 cells; 80-80μg/mL of ZMS treated HL-60 cells; +Ct− Camptothecin treated HL-60 cells. (b) 2 × 106
HL-60 cells were treated with 20μg/mL of ZMS extract and were incubated for 3 hours, 6 hours, 9 hours, 12 hours, and 24 hours. DNA was
electrophoresed at respective time interval on 1.8% Agarose gel and stained with ethidium bromide.
was used for the estimation of lipid peroxidation (LPO) [22]
and glutathione content (GSH) [23]. Rest of the homogenate
was centrifuged at 2500 × gf o r1 5m i n u t e sa t4 ◦Ca n d
superoxide dismutase (SOD) [24], catalase (CAT) [25], and
total protein [26] was estimated in the supernatant.
2.4.7.StatisticalAnalysis. Alltheresultsofinvivoexperiment
were expressed as Mean ± S.E.M. Data of tests were
statistically analyzed using one-way ANOVA followed by
Tukey’s multiple range test, applied for post-hoc analysis.
The data were considered to be statistically signiﬁcant if the
probability had a value of 0.05 or less.
3. Results
3.1. Inhibition of Cell Proliferation in Various Cell Lines
by ZMS. In order to determine the anticancer potency of
extract in vitro, ZMS was tested for cell growth inhibition
in diﬀerent cancer cell lines at various concentrations for 48
hours. The extract did not show any signiﬁcant inhibitory
eﬀect against normal cell line HGF (Normal human gingival
ﬁbroblast cell line). Inhibitory eﬀect against HL-60, Hela,
and Molt-4 was observed with IC50 value at 20μg/mL,
40μg/mL, and 40μg/mL, respectively. Of the tested cell lines,
maximum growth inhibition was observed in HL-60 cells as
shown in Figure 1, and thus HL-60 was selected for further
study.
3.2. Flow Cytometric Analysis of Apoptosis/Necrosis Induced by
ZMS in HL-60 Cells. I no r d e rt od e t e r m i n ew h e t h e rZ M S -
induced cytotoxicity is due to apoptosis or necrosis, HL-60
cellswereincubatedwithdiﬀerentconcentrationsofZMSfor
12 hours, and the percentage of cells undergoing apoptosis
or necrosis was determined by staining with annexin V-FITC
and PI (Figure 2). Cells in the lower right quadrant indicated
apoptosis while in the upper right quadrant represented
postapoptotic necrotic population. ZMS at 5μg/mL and
80μg/mL induced about 18.8% and 61.2% apoptosis. The
increase in annexin V-FITC/PI positive cell population
suggests that ZMS is a potent inducer of apoptosis and
triggers events leading to apoptotic cell death.
3.3. Cell Cycle Analysis by ZMS Treatment. For the conﬁr-
mation of apoptotic cell death induced by ZMS in HL-60
cells, the cells were treated with ZMS for 24 hours. The cells
exhibited concentration-dependent increase in hypodiploid
sub-Go/G1 DNA fraction (<2nDNA) (Figure 3). The sub-
G o / G 1f r a c t i o nw a s<1% in control cells (untreated HL-60
cells) which increased with increasing concentration of ZMS
and reached to 64% at concentration of 80μg/mL.
3.4.DNAFragmentation. DNAfragmentation,acharacteris-
tic feature of apoptosis, was assessed by ladder formation on
agrose gel electrophoresis. HL-60 cells treated with extract
showed apoptosis in a concentration-dependent manner
as evidenced by the formation of internucleosomal DNA
fragments (Figure 4(a)). Apoptosis induction in cells started
at 20μg/mL and this concentration was further selected
for time-dependent study. The extract was found to induce
apoptosis in cells after 3 hours of incubation as shown in
Figure 4(b).
3.5. Survival Time and Tumor Growth Response. Antitumor
activity of ZMS against EAC tumor-bearing mice is shown in
Table 1.Thetumor volume andviablecellcountsigniﬁcantly
increased in EAC control animals. Administration of ZMS
(100, 200, 400, and 800mg/kg b.wt.) to tumor-bearing mice
signiﬁcantly (P<. 001) decreased tumor volume and viable
cell count and enhanced the mean survival time in a dose-
dependent manner. Tumor growth inhibition upto 75.42 ±
0.96% was observed at 800mg/kg b.wt. with 70% increase in
life span of test animals.Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: Change in body weight in EAC bearing mice after ZMS treatment. The results are presented as Mean ± S.E.M. (n = 10). (a)
P<. 001 in comparison to untreated control; (b) P<. 05 in comparison to EAC control group.
Table 1: Eﬀect of ZMS treatment on EAC-bearing mice.
Parameters
Treatment of diﬀerent groups
Control EAC EAC + 5FU EAC + ZMS EAC + ZMS EAC + ZMS EAC + ZMS
Dose (mg/kg b.wt.) 20 100 200 400 800
Hb content (mg/dl) 13 ± 0.5 9.5 ± 0.73a 13.1 ± 0.4b 11.24 ± 0.67b 11.59 ± 0.6b 12.4 ± 0.81b 12.2 ± 0.45b
WBC (cells/mL × 106)7 . 1 7 ± 0.11 15.6 ± 0.64a 7.73 ± 0.68a 12.1 ± 0.75b 9.4 ± 0.83b 9.2 ± 1.26b 8.5 ± 0.40b
RBC (cells/mL × 106)5 . 3 3 ± 0.45 3.5 ± 0.41a 5.2 ± 0.11b 4.2 ± 0.55b 4.3 ± 0.35b 4.9 ± 0.15b 5.0 ± 0.12b
Tumor Volume (mL) — 8.3 ± 0.79 0.7 ± 0.20b 7.6 ± 0.94b 5.4 ± 0.96b 4.5 ± 1.04b 2.1 ± 0.51b
Viable tumor Cell Count (×107) — 283.02 ± 1.63 11.17 ± 0.96b 186.12 ± 1.57b 146.27 ± 1.43b 109.57 ± 1.08b 69.59 ± 1.62b
Mean Survival time (Days) — 20 ± 1.41 39 ± 0.81b 23 ± 1.53b 26 ± 1.73b 30 ± 0.81b 34 ± 1.63
Tumor inhibition (%) — 96.11 ± 0.73 25.67 ± 1.09 39.78 ± 2.55 57.54 ± 1.03 75.42 ± 0.96
Increase in life span (%) — 95 15 30 50 70
The results are presented as Mean ± S.E.M. (n = 10). aP<. 001 in comparison to normal group; bP<. 05 in comparison to EAC control group.
EAC-bearing mice showed rise in body weight, while the
extract treatment inhibited the rise in body weight in the
pattern similar to the standard drug (Figure 5).
3.6. Hematological Parameters. Hematological parameters
of tumor bearing animals on day 13 were found to be
signiﬁcantly altered as compared to normal group (Table 1).
Hemoglobin content and RBC count in EAC control group
decreased while WBC count increased as compared to nor-
mal group. Treatment with ZMS at various doses increased
hemoglobin content and RBC count and reduced the WBC
count towards normalcy.
3.7. Lipid Peroxidation and Glutathione. Increase in malon-
dialdehyde (MDA) levels is a measure of lipid peroxidation.
Figure 6 depicts the level of lipid peroxidation in terms
of MDA in liver tissue of experimental animals. It was
observed that MDA levels increased by 60.6% in EAC control
group as compared to normal control group (P<. 001).
After administration of ZMS at diﬀerent doses (100, 200,
400, and 800mg/kg) to EAC-bearing mice, the level of
lipid peroxidation reduced by 12.22%, 21.83%, 31.44%, and
43.23%,respectively,ascomparedtoEACcontrolgroup(P<
.05).
Figure 7 illustrates the eﬀect of ZMS on reduced glu-
tathione in EAC-bearing mice. Tumor induction by inoc-
ulation of EAC drastically decreased the GSH content by
70% (P<. 001) in control group. The administration of
ZMS at 100, 200, 400 and 800mg/kg to EAC bearing animals
increased the GSH content by 21.97%, 30.39%, 37.71% and
41.32%, respectively, as compared to untreated EAC control
group (P<. 05).
3.8. Antioxidant Enzymes. ZMS signiﬁcantly restored the
antioxidant status of tumor-bearing mice. The eﬀect of
administration of ZMS to EAC bearing animals at 100,8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Reduction in lipid peroxidation in EAC-bearing mice
after ZMS treatment. The results are presented as Mean ± S.E.M.
(n = 10). (a) P<. 001 in comparison to normal control; (b) P<. 05
in comparison to EAC control group.
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Figure 7: Augmentation of glutathione content in EAC bearing
mice after ZMS treatment. The results are presented as Mean ±
S.E.M. (n = 10). (a) P<. 001 in comparison to normal control;
(b) P<. 05 in comparison to EAC control group.
200, 400, and 800mg/kg eﬃciently enhanced the superoxide
dismutase activity by 11.01%, 24.62%, 31.52%, and 47.12%,
respectively, as compared to EAC control group (Figure 8).
Catalase activity was evaluated in terms of H2O2
reduced/min/mg of protein. The catalase level in EAC
bearing mice was found to decrease by 57.80% as compared
to normal control group (P<. 001). However, treatment
of EAC bearing mice with diﬀerent doses of ZMS enhanced
the catalase activity in a dose-dependent manner (Figure 9).
At the highest dose of 800mg/kg, rise in catalase activity
was found to be 44.31% as compared to EAC control group
(P<. 05).
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Figure 8: Augmentation of superoxide dismutase activity in EAC
bearing mice after ZMS treatment. The results are expressed as
Mean ± S.E.M. (n = 10). (a) P<. 001 in comparison to normal
control; (b) P<. 05 in comparison to EAC control group.
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Figure 9: Augmentation of catalase activity in EAC bearing mice
after ZMS treatment. The results are expressed as Mean ± S.E.M.
(n = 10). (a) P<. 001 in comparison to normal control; (b) P<. 05
in comparison to EAC control group.
4. Discussion
Oneofthegoalsofanticancerpotentialofanydrug/extractis
the induction of apoptosis in cancer cells [27]. Apoptosis or
programmed cell death is one of the most important targets
for cancer treatment comprising chemotherapy as well as
chemoprevention. It is characterized by membrane blebbing,
cytoplasmic condensation, formation of apoptotic bodies,
DNA fragmentation, alteration in membrane symmetry,
activation of cascade of caspases, and loss of mitochondrial
membrane potential [28]. In the present study, cytotoxic
potential of ZMS was assessed by MTT assay against cancer
cell lines (HL-60, Molt-4, HeLa). Assay is based uponEvidence-Based Complementary and Alternative Medicine 9
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Figure 10: Presumptive mechanism of apoptosis induction by ZMS. ZMS may aﬀect the genes and transcription factors or may aﬀect
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leading to cell death via apoptosis.
reduction of yellow tetrazolium salt (MTT) by metabolically
active cells to a dark blue formazan [29], which has been
employed by many workers to measure cytotoxicity to cells
[30, 31]. ZMS showed signiﬁcant cytotoxic eﬀect against
diﬀerent cell lines with minimum IC50 value of 20μg/mL
against HL-60 cells and no signiﬁcant cytotoxicity to normal
cell line was observed. The criteron of cytotoxicity activity
for crude extracts established by American National Cancer
Institute is an IC50 value of <30μg/mL in preliminary assay
[32], which was observed only against HL-60 cells and hence
further investigations were carried out using HL-60 cell line.
To investigate the mechanism of cell death induced by ZMS
in HL-60 cells, ﬂow cytometric analysis was done by PI and
annexin V-FITC labelling to conﬁrm apoptosis/necrosis as a
marker to assess apoptosis [33]. During apoptosis, a number
of changes occur in cell surface markers that show aﬃnity
for PI and annexin V-FITC labelling [34]. The results of
the present study indicated an increase in apoptotic popu-
lation induced by the extract in a concentration-dependent
manner. Earlier Malik et al. [35] reported withaferin A as
apoptosis inducer utilizing ﬂow cytometric analysis. Another
important characteristic of apoptosis induction is DNA
fragmentation and measurement of DNA content makes it
possible to identify apoptotic cells. To recognize the cell cycle
phasespeciﬁcityandtoquantifyapoptosis,propidiumiodide
(PI) dye binds to DNA in cells at all stages of the cell cycle,
and the intensity with which a cell nucleus emits ﬂuorescent
lightisdirectlyproportionaltoitsDNAcontent.Theincrease
in hypo diploid sub Go population in our results indicates
the induction of apoptosis, as sub Go peak is reported to
be a quantitative indicator of apoptosis [16]. Uvaretin, Isou-
varetin, and Diuvaretin are known triterpenoid established
as apoptosis inducer using the same parameters [36]. DNA
fragmentation was conﬁrmed by agarose gel electrophoresis.
The nuclear DNA of apoptotic cells shows a characteristic
laddering pattern of oligonucleosomal fragments, which is
regarded as the hallmark of apoptosis [37].
Plant extract at various doses was tested in vivo against
Ehrlich ascite carcinoma induced tumor in Swiss albino
mice. Ascite ﬂuid is the direct nutritional source for tumor
cells and a rapid increase in ascite ﬂuid with tumor growth
would be a mean to meet the nutritional requirement of
tumor cells [38]. Treatment with ZMS inhibited tumor
volume and viable cell count and also increased the life span
of tumor-bearing mice. Prolongation of life span of animal
has been well documented as criteria for judging the drug
activity [39]. Myelosuppression and anaemia are the major
problemsofcancerchemotherapy[40].T r eatmentwithZMS
reverted back the Hb content, RBC, and WBC count towards
normalcy showing its protective action on hematopoetic10 Evidence-Based Complementary and Alternative Medicine
system. Our results are in corroboration with the ﬁndings of
Gupta et al. [41]w h or e p o r t e das i m i l a re ﬀect of Indigofera
aspalathoides against Ehrlich ascites carcinoma.
Excessive production of free radicals results in oxidative
stress which leads to damage of macromolecules like lipids
and induces lipid peroxidation [42, 43]. Malondialdehyde
(end product of lipid peroxidation) has been reported to
increase in carcinomous tissues than nondiseased organs
[44]. Glutathione, a potent inhibitor of neoplastic process is
found particularly in liver and known to exhibit protective
function against free radicals [42]. In the present study,
ZMS treatment reduced lipid peroxidation and enhanced
glutathione content in tumor-bearing animals. Superoxide
dismutase and catalase are free radical scavenging enzymes
present in all oxygen metabolizing cells and provide defence
against potentially damaging entities of superoxide and
hydrogen peroxide. Inhibition of both the enzymes as a
result of tumor growth observed in the present study is in
corroboration with earlier reports [45]. Administration of
ZMS at diﬀerent doses increased the SOD and CAT levels in
a dose-dependent manner indicating the protective function
of ZMS. In our previous study [14], phytochemical analysis
of the extract showed the presence of betulinic acid which
is a known anticancer agent [11] and the antitumor and
apoptosis inducing property of extract may be in part due
to the presence of betulinic acid. It is well established that
betulinic acid activates apoptosis independent of the death
receptors (CD95/Fas), but induces the successive activation
of caspase 9 and caspase 3 [46, 47]. The phytochemical
analysis of the extract in our previous study has also revealed
the presence of alkaloids and ﬂavonoids, which could also
be expected to be responsible for its bioactivity. Although
at this stage the exact mechanism underlying apoptosis
induction by extract is diﬃcult to predict, yet it could be
due to activation of mitochondrial pathway or its eﬀect on
proteosome or other gene and transcription factors. The
hypothetical mechanism is outlined in Figure 10.
In conclusion, the present study highlights the antitumor
and cytotoxic potential of seed extract of Ziziphus mauri-
tiana. Further studies to characterize the active principles
and elucidate the mechanism of action are in progress.
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